CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
1.380
+0.005 (0.36%)
At close: Jun 27, 2025, 4:00 PM
1.440
+0.060 (4.35%)
After-hours: Jun 27, 2025, 7:56 PM EDT
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$43,368
Profits / Employee
-$243,263
Market Cap
15.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CLGN News
- 19 days ago - COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES - PRNewsWire
- 24 days ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS - PRNewsWire
- 4 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES - PRNewsWire
- 4 weeks ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PRNewsWire
- 6 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS - PRNewsWire
- 2 months ago - CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies - PRNewsWire
- 3 months ago - CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PRNewsWire